Stem cell transplants, a potential cure for life-threatening diseases

Entre Nous

A stem cell transplant is a procedure that can treat or cure a number of conditions: bone marrow diseases, inherited immune disorders, hemoglobinopathies and some types of cancer. Dr. Gizelle Popradi, hematologist and director of the Stem Cell Transplant Program of the McGill University Health Centre tells us more about this life-saving therapy and its use in the treatment of cancer patients.

Les cellules souches, de précieuses alliées

Entre Nous

Une greffe de cellules souches est une intervention qui peut traiter ou guérir diverses maladies : des maladies de la moelle osseuse, des hémoglobinopathies (anomalies des globules rouges) et des troubles immunitaires congénitaux, de même que certains types de cancer, tels que les leucémies, les lymphomes et les myélomes. La Dre Gizelle Popradi, hématologiste et directrice du programme de greffe de cellules souches du Centre universitaire de santé McGill (CUSM), nous en dit un peu plus sur ce traitement salvateur et sur son usage pour soigner les patients atteints d’un cancer.

Major Indigenous initiatives coming to McGill in the next year


It will be a busy and interesting year ahead for those involved in Indigenous issues and events. Two major developments are on the horizon, in addition to McGill’s regular activities that focus on Indigenous experiences and developing connections with Indigenous communities.

Donald Taylor: Fuelled by folk music and nuclear physics


McGill Medal winner, Donald Taylor looks back at a long and distinguished career championing some of the world’s most disadvantaged people.

John Bergeron: “Only young people make discoveries”


Recently, McGill’s John Bergeron, one of Canada’s preeminent cell biologists, was invited to be a judge at the Canada-Wide Science Festival (CWSF). Bergeron jump at the chance because it closed a circle over 50 years in the making. “The CWSF started my career at McGill,” says Bergeron. “In 1961, I won the Science Fair at the University of Montreal and that paid for my first year of McGill.”

Philip Branton: More funding for basic science


Philip Branton knows a lot about cancer. Branton, the Gilman Cheney Professor at the Department of Oncology and Biochemistry is an internationally renowned virologist with over 40 years of cancer research experience. But, if Branton has learned anything over the course of his long, distinguished career it is that “there is still so much we just don’t understand about cancer.”

$17M to shape the future of music


A partnership between McGill and Université de Montréal will create a new kind of hybrid research space, but instead of building more laboratories, the universities’ music schools are joining two spaces, half the city apart, with digital technology.

17 M $ pour façonner l’avenir de la musique


Grâce à un partenariat entre l’Université McGill et l’Université de Montréal, une enceinte de recherche hybride nouveau genre verra le jour. Il ne s’agit pas ici de bâtir des laboratoires, mais bien de réunir deux salles, situées de part et d’autre de la ville, par la magie du numérique.

Profile: Robert Platt, Chair in Pharmacoepidemiology


A native of Winnipeg, Manitoba, Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health, and the inaugural Albert Boehringer (1st) Chair in Pharmacoepidemiology, has long been fascinated with numbers.

FAEQ awards $30,000 in bursaries to incoming McGill student-athletes


Six incoming freshmen to McGill have been pegged to share $30,000 and are among the 35 recipients of recruitment bursaries totalling $165,000, announced last week by the Quebec Foundation for Athletic Excellence. The amount includes five awards of $3,000 apiece, distributed to Canadians from outside Quebec who have chosen to pursue their educational and athletic careers in a Quebec university.